Yüklüyor......

Circulating biomarkers to monitor cancer progression and treatment

Tumor heterogeneity is a major challenge and the root cause of resistance to treatment. Still, the standard diagnostic approach relies on the analysis of a single tumor sample from a local or metastatic site that is obtained at a given time point. Due to intratumoral heterogeneity and selection of s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Comput Struct Biotechnol J
Asıl Yazarlar: Rapisuwon, Suthee, Vietsch, Eveline E., Wellstein, Anton
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Research Network of Computational and Structural Biotechnology 2016
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4913179/
https://ncbi.nlm.nih.gov/pubmed/27358717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.csbj.2016.05.004
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!